The need for transfusions in patients with lower risk myelodysplastic syndrome (MDS). Data from the regular care MDS-registry in Germany

被引：0
|
作者：
Steinmetz, T. [1 ]
Toczek-Thiel, J. [1 ]
Hellmich, M. [2 ]
Aludin, R. [1 ]
Lipke, J. [3 ]
Liersch, R. [4 ]
Sauer, A. [5 ]
Tesch, H. [6 ]
Hessling, J. [7 ]
Schmitz, S. [8 ]
机构：
[1] Onkol Koln, Hamatol, Cologne, Germany
[2] Univ Klin Koln, Inst Med Stat & Bioinformat, Cologne, Germany
[3] Praxis Hamatol & Onkol, Dortmund, Germany
[4] Praxis Hamatol & Onkol, Munster, Germany
[5] Praxis Hamatol & Onkol, Potsdam, Germany
[6] Praxis Hamatol & Onkol, Frankfurt, Germany
[7] Praxis Hamatol & Onkol, Berlin, Germany
[8] Onkol Koln, Onkol, Cologne, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2018年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P298
引用
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [1] Incidence and prevalence of myelodysplastic syndromes: Data from the Dusseldorf MDS-registry
    Neukirchen, Judith
    Schoonen, Wilma M.
    Strupp, Corinna
    Gattermann, Norbert
    Aul, Carlo
    Haas, Rainer
    Germing, Ulrich
    LEUKEMIA RESEARCH, 2011, 35 (12) : 1591 - 1596
  • [2] AGE DISTRIBUTION OF PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS) IN GERMANY AND THEIR PROGNOSIS ACCORDING TO THE INTERNATIONAL PROGNOSTIC SCORING SYSTEM (IPSS): DATA FROM THE REGULAR CARE MDS REGISTRY
    Steinmetz, H. T.
    Boettger, I.
    Wahdat, R.
    Haastert, B.
    Lathan, B.
    Sauer, A.
    Germing, U.
    Schmitz, S.
    HAEMATOLOGICA, 2016, 101 : 242 - 242
  • [3] Need of transfusions, treatment and survival of patients with Myelodysplastic Syndromes (MDS): Update of the outpatient MDS registry
    Steinmetz, H. T.
    Boettger, I
    Lathan, B.
    Sauer, A.
    Severin, K.
    Germing, U.
    Schmitz, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 234 - 234
  • [4] TRANSFUSIONS AND PRESENCE OF RINGSIDEROBLASTS INFLUENCE HEPCIDIN AND NTBI LEVELS IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (MDS) - A REPORT FROM THE EUROPEAN LEUKEMIANET MDS REGISTRY
    de Swart, L.
    Reiniers, C.
    Bagguley, T.
    Van Marrewijk, C.
    Bowen, D.
    Cermak, J.
    Hellstrom-Lindberg, E.
    Tatic, A.
    Symeonidis, A.
    Huls, G.
    Panagiotidis, P.
    Garelius, H.
    Culligan, D.
    Krejci, M.
    Droste, J.
    Smith, A.
    Swinkels, D.
    de Witte, T.
    LEUKEMIA RESEARCH, 2015, 39 : S106 - S107
  • [5] Myelodysplastic syndromes (MDS) in regular care in Germany - the oldest patients come to the fore
    Steinmetz, Hans Tilman
    Germing, Ulrich
    Sauer, Annette
    Lathan, Bernd
    Liersch, Ruediger
    Tesch, Hans
    Hessling, Joerg
    Moorahrend, Enno
    Uhlig, Jens
    Reiser, Marcel
    Wahdat, Roja
    Gattermann, Norbert
    Totzke, Uwe
    Schmitz, Stephan
    LEUKEMIA & LYMPHOMA, 2018, 59 (05) : 1244 - 1247
  • [6] Cause of death and excess mortality in patients with lower-risk myelodysplastic syndromes (MDS): A report from the European MDS registry
    Madry, Krzysztof
    Lis, Karol
    Fenaux, Pierre
    Bowen, David
    Symeonidis, Argiris
    Mittelman, Moshe
    Stauder, Reinhard
    Cermak, Jaroslav
    Sanz, Guillermo
    Hellstrom-Lindberg, Eva
    Langemeijer, Saskia
    Malcovati, Luca
    Germing, Ulrich
    Holm, Mette Skov
    Guerci-Bresler, Agnes
    Culligan, Dominic
    Sanhes, Laurence
    Kotsianidis, Ioannis
    van Marrewijk, Corine
    Crouch, Simon
    de Witte, Theo
    Smith, Alex
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (04) : 451 - 461
  • [7] Treatment Outcome of Patients with Myelodysplastic Syndromes (MDS) in Regular Care: Incidence of IPSS Risk Groups and Different Therapies in the German Outpatient MDS Registry
    Steinmetz, H. Tilman
    Boettger, Isolde
    Lathan, Bernd
    Sauer, Annette
    Moorahrend, Enno
    Severin, Kai
    Germing, Ulrich
    Schmitz, Stephan
    Gattermann, Norbert
    BLOOD, 2014, 124 (21)
  • [8] Cause of death in patients with lower-risk myelodysplastic syndrome (MDS)
    Conley, A. P.
    Stevenson, W.
    Pierce, S.
    Cortes, J. E.
    O'Brien, S. M.
    Ravandi, F.
    Kantarjian, H. M.
    Garcia-Manero, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Azacitidine (AZA) for Patients with Vexas and Myelodysplastic Syndrome (MDS): Data from the French Vexas Registry
    Comont, Thibault
    Heiblig, Mael
    Dion, Jeremie
    Riviere, Etienne
    Terriou, Louis
    Rossignol, Julien
    Rieu, Virginie
    Le Guenno, Guillaume
    Mathian, Alexis
    Aouba, Achille
    Vinit, Julien
    Terrier, Benjamin
    Kosmider, Olivier
    Georgin-Lavialle, Sophie
    Fenaux, Pierre
    Mekinian, Arsene
    BLOOD, 2021, 138 : 3689 - +
  • [10] Characteristics of patients with acute myeloid leukaemia (AML) diagnosed in regular care. Data from the regular care AML-MDS-registry in Germany
    Steinmetz, T.
    Aludin, R.
    Lipke, J.
    Liersch, R.
    Sauer, A.
    Tesch, H.
    Hessling, J.
    Schmitz, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 252 - 253
12345